A preclinical study11 in a head and neck squamous cell carcinoma model system found that antiangiogenic strategies (VEGF inhibition) in combination with radiation were associated with favorable tumor response outcomes. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.